Dachaigh › Lymphoma Cealla-T Peripheral
Sgrùdaidhean clionaigeach Lymphoma Cealla-T Peripheral a’ fastadh anns na SA
Tha 19 sgrùdaidhean airson Lymphoma Cealla-T Peripheral a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Houston, TX9 sgrùdaidhean
- New York City, NY6 sgrùdaidhean
- Boston, MA5 sgrùdaidhean
- Baldwin Park, CA5 sgrùdaidhean
- Atlanta, GA4 sgrùdaidhean
- Philadelphia, PA4 sgrùdaidhean
- Aurora, CO3 sgrùdaidhean
- Ann Arbor, MI3 sgrùdaidhean
- Columbus, OH3 sgrùdaidhean
Le stàit
- California8 sgrùdaidhean
- Colorado3 sgrùdaidhean
- Florida4 sgrùdaidhean
- Georgia4 sgrùdaidhean
- Massachusetts5 sgrùdaidhean
- Michigan5 sgrùdaidhean
- New Jersey3 sgrùdaidhean
- New York7 sgrùdaidhean
- Ohio5 sgrùdaidhean
- Pennsylvania6 sgrùdaidhean
- Texas10 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
A’ fastadhÌre 1
Aoisean 12 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06176690Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
A’ fastadhSgrùdadh amharc
Aoisean 0 gu 38 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06131801A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07192471A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of Newly Diagnosed Peripheral T Cell Lymphoma Patients (GOLDEN Study) and Correlative Study
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06630091Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06561048CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
A’ fastadhÌre 2
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT04083495A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07195916AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
A’ fastadhÌre 1/2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT06137144Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
A’ fastadhÌre 1 tràth
Aoisean 1 gu 31 · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT03719105Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT07750886A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT04045470To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT06072131Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Iuch 2026 · NCT06508463Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Ògmh 2026 · NCT04068597Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Ògmh 2026 · NCT05313243Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT07356245Amping up With PemJAK
A’ fastadhÌre 2
Aoisean 18 gu 95 · Gach gnè · Air ùrachadh 16 Dùbh 2025 · NCT07283822Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2025 · NCT04234048Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2025 · NCT03964480Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.